Tanja Talvikki Holopainen

Person

Latest publications

  1. Treating cachexia using soluble ACVR2B improves survival, alters mTOR localization, and attenuates liver and spleen responses

    Nissinen, T. A., Hentilä, J., Penna, F., Lampinen, A., Lautaoja, J. H., Fachada, V., Holopainen, T., Ritvos, O., Kivelä, R. & Hulmi, J. J., Jun 2018, In : Journal of cachexia, sarcopenia and muscle. 9, 3, p. 514-529 16 p.

    Research output: Contribution to journalArticleScientificpeer-review

  2. TIE

    Saharinen, P. & Holopainen, T., 2017, Cancer Therapeutic Targets. Marshall, J. L. (ed.). New York: Springer, Vol. 2-2. p. 611-624

    Research output: Chapter in Book/Report/Conference proceedingChapterScientificpeer-review

  3. Elevated VEGF-D Modulates Tumor Inflammation and Reduces the Growth of Carcinogen-Induced Skin Tumors

    Honkanen, H-K., Izzi, V., Petaisto, T., Holopainen, T., Harjunen, V., Pihlajaniemi, T., Alitalo, K. & Heljasvaara, R., Jul 2016, In : NeoPlasia. 18, 7, p. 436-446 11 p.

    Research output: Contribution to journalArticleScientificpeer-review

View all (27) »

ID: 92756